These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7331894)

  • 1. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
    Böttiger LE; Böttiger B
    Acta Med Scand; 1981; 210(6):475-9. PubMed ID: 7331894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced blood dyscrasias in Sweden.
    Böttiger LE; Westerholm B
    Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.
    Maluf E; Hamerschlak N; Cavalcanti AB; Júnior AA; Eluf-Neto J; Falcão RP; Lorand-Metze IG; Goldenberg D; Santana CL; Rodrigues Dde O; Passos LN; Rosenfeld LG; Pitta M; Loggetto S; Ribeiro AA; Velloso ED; Kondo AT; Coelho EO; Pintão MC; de Souza HM; Borbolla JR; Pasquini R
    Haematologica; 2009 Sep; 94(9):1220-6. PubMed ID: 19734415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative incidence of agranulocytosis and aplastic anemia.
    Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
    Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study.
    Hamerschlak N; Maluf E; Pasquini R; Eluf-Neto J; Moreira FR; Cavalcanti AB; Okano IR; Falcão RP; Pita MT; Loggetto SR; Rosenfeld LG; Lorand-Metze IG
    Sao Paulo Med J; 2005 May; 123(3):101-4. PubMed ID: 16021270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
    Rawson NS; Harding SR; Malcolm E; Lueck L
    J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.
    Blood; 1987 Dec; 70(6):1718-21. PubMed ID: 3676511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematological reactions.
    Huguley CM
    JAMA; 1966 May; 196(5):408-10. PubMed ID: 5952218
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
    Levy M; Kelly JP; Kaufman DW; Shapiro S
    Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].
    TRAISSAC FJ; BERAUD C; DANGOUMAU J
    Bull World Health Organ; 1964; 31(1):95-100. PubMed ID: 14230898
    [No Abstract]   [Full Text] [Related]  

  • 14. Agranulocytosis and aplastic anemia among Ramathibodi Hospital patients.
    Jootar S; Chaisiripoomkere W; Rojanasthien S
    J Med Assoc Thai; 1992 Sep; 75(9):514-6. PubMed ID: 1304020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality resulting from blood dyscrasias in the United States, 1984.
    Hine LK; Gerstman BB; Wise RP; Tsong Y
    Am J Med; 1990 Feb; 88(2):151-3. PubMed ID: 2301442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRUG-INDUCED BLOOD DYSCRASIAS.
    HUGULEY CM
    Dis Mon; 1963 Oct; 24():1963:1-52. PubMed ID: 14051625
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-associated blood dyscrasias. Recent additions to the Registry.
    BEST WR
    JAMA; 1963 Jul; 185():286-90. PubMed ID: 13967788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug hypersensitivity].
    Cruchaud S; Frei PC
    Schweiz Med Wochenschr; 1967 Nov; 97(47):1568-71. PubMed ID: 5596884
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.